InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2021-10-22 00:00:00 ET · period of report 2021-10-20 · accession 0001209191-21-061373 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-10-22 2021-10-20 PCVX PICKERING GRANT CEO, Dir M - OptEx $1.79 +15.0K 595.3K +3% +$26.9K
DM 2021-10-22 2021-10-20 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $22.58 -15.0K 581.3K -3% -$338.8K
D 2021-10-22 2021-10-20 PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 -15.0K 343.8K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-20 M A 15,000 $1.79 595,254 D — —
2 Common Common Stock 2021-10-20 S D 1,009 $23.19 580,254 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $23.13 to $23.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2021-10-20 S D 13,991 $22.54 581,263 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $22.10 to $23.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (right to buy) 2021-10-20 M D 15,000 $0.00 343,815 D $1.79 · — to 2027-05-17 15,000 Common Stock (F4) The shares subject to the option are fully vested and exercisable.